• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. LGN POROUS CR FEM SZ 4R; PROSTHESIS, KNEE, PATELLO/FEMOROTIBIAL, SEMI-CONSTRAINED, UNCEMENTED, POROUS, CO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. LGN POROUS CR FEM SZ 4R; PROSTHESIS, KNEE, PATELLO/FEMOROTIBIAL, SEMI-CONSTRAINED, UNCEMENTED, POROUS, CO Back to Search Results
Catalog Number 71423254
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Loss of Range of Motion (2032)
Date of Event 12/19/2023
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that, after a tka surgery performed on (b)(6) 2023, the patient experienced a loss of range of motion.This adverse event was addressed with manipulation under anesthesia on (b)(6) 2023 and treated with medication.The current health status of the patient is unknown.
 
Additional Manufacturer Narrative
H10: internal complaint reference: (b)(4).
 
Additional Manufacturer Narrative
The devices were not returned for evaluation; therefore, a device analysis could not be performed.The clinical/medical investigation concluded that, loss of range of motion approximately two months after a revision total knee arthroplasty.It is not related to the device or the procedure.The electronic clinical report form provided were used for the investigation.Consequently, as of the date of this medical investigation, the requested relevant clinical documentation has not been provided; therefore, there were no clinical factors found which would have caused or contributed to the reported adverse event.Loss of range of motion is a known complication of major knee surgeries due to excessive scar tissue formation.Therefore, this adverse event is related to the procedure, and it is not considered a foreseeable harm associated with the smith and nephew products.According to the report, the loss of range of motion was treated by a manipulation under anesthesia and with medication.The impact to the patient beyond the reported loss of range of motion, manipulation under anesthesia, and medication cannot be determined since it was reported the patient outcome is unknown.Therefore, no further clinical/medical assessment can be rendered at this time.A review of the production orders did not reveal a manufacturing abnormality that could have caused or contributed to the reported incident.A review of complaint history for the part numbers over the past 12 months and for the batch numbers based on historical data of the devices did not reveal similar events for the listed devices.A review of the instructions for use documents for knee systems revealed in possible adverse effects that decreased range of motion and unusual stress concentrations can result from trauma, improper implant selection, improper implant positioning, improper fixation, and/or migration of the components.Muscle and fibrous tissue laxity can also contribute to these conditions.A review of the risk management files revealed this failure mode was previously identified.The anticipated risk level is still adequate.A historical review concluded that there are no prior actions related to these products and event.At this time, we have no evidence to conclude that the products failed to meet any specifications at the time of manufacture.Factors that could contribute to the reported event is healing factors.Based on this investigation, the need for corrective action is not indicated.Should the devices or additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LGN POROUS CR FEM SZ 4R
Common Device Name
PROSTHESIS, KNEE, PATELLO/FEMOROTIBIAL, SEMI-CONSTRAINED, UNCEMENTED, POROUS, CO
Manufacturer (Section D)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer (Section G)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key18933426
Report Number1020279-2024-00569
Device Sequence Number14587959
Product Code MBH
UDI-Device Identifier00885556031674
UDI-Public00885556031674
Combination Product (Y/N)N
Initial Reporter StateSC
Initial Reporter CountryUS
PMA/510(K) Number
K073325
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Study,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/16/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number71423254
Device Lot Number20MHA0029A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/26/2024
Supplement Date Received by Manufacturer04/12/2024
Initial Report FDA Received Date03/19/2024
Supplement Report FDA Received Date04/16/2024
Date Device Manufactured09/21/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ACETAMINOPHEN (1000 MG) ONCE ONLYOXYCODONE IR (5
Outcome Attributed to Adverse Event Required Intervention;
Patient Age68 YR
Patient SexFemale
Patient Weight72 KG
-
-